BiotechTube
Home/STALICLA/Dr. Paul Wang
DP

Dr. Paul Wang

Head of Development

STALICLA

Therapeutic Areas

Neurodevelopmental DisordersAutism Spectrum DisorderBrain Disorders

STALICLA Pipeline

DrugIndicationPhase
STP1Autism Spectrum Disorder (specific subgroup)Phase 2
STP2Autism Spectrum Disorder (specific subgroup)Preclinical

Leadership Team at STALICLA

LD
Lynn Durham
Founder & CEO
DC
Dr. Carina R. Bichsel
Chief Operating Officer
DC
Dr. Carine de Beaufort
Chief Medical Officer
View full STALICLA profile